1. Home
  2. BW vs STOK Comparison

BW vs STOK Comparison

Compare BW & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Babcock & Wilcox Enterprises Inc.

BW

Babcock & Wilcox Enterprises Inc.

HOLD

Current Price

$7.92

Market Cap

1.2B

Sector

Industrials

ML Signal

HOLD

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$29.24

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BW
STOK
Founded
1867
2014
Country
United States
United States
Employees
1650
N/A
Industry
Building Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
2.0B
IPO Year
2015
2019

Fundamental Metrics

Financial Performance
Metric
BW
STOK
Price
$7.92
$29.24
Analyst Decision
Buy
Strong Buy
Analyst Count
2
10
Target Price
$8.00
$39.20
AVG Volume (30 Days)
4.9M
693.6K
Earning Date
05-11-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
41.46
92.73
EPS
N/A
N/A
Revenue
$1,062,388,000.00
$184,420,000.00
Revenue This Year
$41.58
N/A
Revenue Next Year
$66.70
$77.49
P/E Ratio
N/A
N/A
Revenue Growth
N/A
404.50
52 Week Low
$2.64
$20.32
52 Week High
$22.03
$40.22

Technical Indicators

Market Signals
Indicator
BW
STOK
Relative Strength Index (RSI) 38.39 37.86
Support Level $6.75 $28.02
Resistance Level $11.34 $33.61
Average True Range (ATR) 0.47 1.31
MACD 0.08 -0.34
Stochastic Oscillator 23.51 8.70

Price Performance

Historical Comparison
BW
STOK

About BW Babcock & Wilcox Enterprises Inc.

Babcock & Wilcox Enterprises Inc is an energy technologies provider offering energy and emissions control solutions to a broad range of industrial, electrical utility, municipal, and other customers. It offers technologies that utilize coal, natural gas, hydrogen, waste, and biomass to produce energy, environmental solutions, and carbon capture systems. The company's product portfolio comprises steam generation systems, environmental solutions, combustion and fuel systems, and related equipment and services. Additionally, it offers specialized technologies (BrightLoop) in industrial energy production, including hydrogen and syngas. Geographically, the company generates maximum revenue from the United States, and the rest from Canada, the UK, Indonesia, the Philippines, and other markets.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: